Tgf-β1 expression as a biomarker of poor prognosis in prostate cancer.
about
Mechanistic basis and clinical relevance of the role of transforming growth factor-β in cancerUpregulation of long non-coding RNA PlncRNA-1 promotes proliferation and induces epithelial-mesenchymal transition in prostate cancer.PSA and Prostate Health Index based prostate cancer screening in a hereditary migration complicated population: implications in precision diagnosis.Hematopoietic stem cell-derived cancer-associated fibroblasts are novel contributors to the pro-tumorigenic microenvironmentTGF-β1 expression is associated with invasion and metastasis of intrahepatic cholangiocarcinoma.Identification of plasma protein profiles associated with risk groups of prostate cancer patientsA local paracrine and endocrine network involving TGFβ, Cox-2, ROS, and estrogen receptor β influences reactive stromal cell regulation of prostate cancer cell motility.Skeletal metastasis: treatments, mouse models, and the Wnt signaling.Molecular and genetic aspects of oncology and infectology in Clinics.Lack of reliability of nanotechnology in the of free plasma DNA in samples of patients with prostate cancer.Prostate cancer health disparities: An immuno-biological perspective.Differential role of PTEN in transforming growth factor β (TGF-β) effects on proliferation and migration in prostate cancer cells.Regulation of transforming growth factor is involved in the efficacy of combined 5-fluorouracil and interferon alpha-2b therapy of advanced hepatocellular carcinoma.TGFβ-induced epithelial-to-mesenchymal transition in prostate cancer cells is mediated via TRPM7 expression.Correlation between DEC1/DEC2 and epithelial‑mesenchymal transition in human prostate cancer PC‑3 cells
P2860
Q26771386-FC9CBE40-75A4-451A-B5FE-372E6CCE4EA2Q33688540-14B5E55F-A26B-484A-83A5-9FEDE57F49AAQ33776728-506E7C36-FF01-454A-905B-749402FB0145Q35745090-12B6A480-C057-4F55-8200-F25ECDA97509Q35885365-6CD4F9D6-055F-4ED1-AB4F-C62705C9F0DFQ35940183-C91587E9-5D05-4984-96B8-E266462ADAAFQ35970073-234F68D2-538C-473C-87B7-148B2D4EFD2CQ37354085-1C4A7394-6970-4F11-9584-A0BF74E10562Q42410325-1C7C284A-E60D-498E-967A-4A34EC636940Q43220277-904B4BE7-7D3A-46AE-A0E3-4F6830087D7FQ46537204-4A95996F-A82D-4AED-9AFE-2BB30D9A17F4Q48229042-96C7E383-1DBA-4A5E-88B4-E185DDDA1DA2Q55216911-392EA453-78B3-4515-8279-425575E526ECQ55251510-BF7B0699-B215-447B-9FD4-6C933EED37F6Q58792238-C5DB30A4-796C-4048-9081-34A56AB8231D
P2860
Tgf-β1 expression as a biomarker of poor prognosis in prostate cancer.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Tgf-β1 expression as a biomarker of poor prognosis in prostate cancer.
@en
Tgf-β1 expression as a biomarker of poor prognosis in prostate cancer.
@nl
type
label
Tgf-β1 expression as a biomarker of poor prognosis in prostate cancer.
@en
Tgf-β1 expression as a biomarker of poor prognosis in prostate cancer.
@nl
prefLabel
Tgf-β1 expression as a biomarker of poor prognosis in prostate cancer.
@en
Tgf-β1 expression as a biomarker of poor prognosis in prostate cancer.
@nl
P2093
P2860
P1433
P1476
Tgf-β1 expression as a biomarker of poor prognosis in prostate cancer.
@en
P2093
Alberto Azoubel Antunes
Alexandre Crippa
Carlo Camargo Passerotti
Daniel Kanda Abe
Jose Pontes-Júnior
José Arnaldo Shiomi da Cruz
Juliana Moreira de Sousa-Canavez
Kátia Ramos Moreira Leite
Leopoldo A Ribeiro-Filho
Marcos Francisco Dall'oglio
P2860
P304
P577
2011-01-01T00:00:00Z